Opioid addiction implant maker Braeburn Pharma pulls IPO: Reuters
Braeburn Pharmaceuticals Inc, the maker of the first long-acting implant to treat opioid addiction in the United States, said on Thursday that it had decided not to proceed with its initial public offering, citing current market environment.
3 February 2017•1 min read
